Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Cologne
Age
60–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
out-patient status
male or female, age ≥ 60 years
ability to provide informed consent and written informed consent signed
DSM-5 diagnosis of a Major Depressive Disorder/MDD (depressive episode at least moderate to severe)
score of at least 10 on the Geriatric Depression Scale (GDS)
score of at least 10 on the Quick Inventory of Depressive Symptomatology - Clinician Rating (QIDS-C)
score of at least 25 in the Mini-Mental-Status-Test (MMST)
no or stable (≥ 6 weeks) antidepressive pharmacological treatment at baseline (medication will be kept stable at least throughout the 8 weeks of treatment).
sufficient German language skills
You may not be if
Bipolar depression
Schizophrenia or other psychotic disorders
Substance abuse or dependency
Dementia
Acute suicidality
Anxiety disorder as stand-alone diagnosis (e.g. generalized anxiety disorder, panic disorder, social phobia)
Obsessive-compulsive disorder (OCD) as stand-alone diagnosis
Participation in any another clinical trial parallel to this trial
Additional psychological/psychotherapeutic treatment throughout the 8-week treatment period
Regular use with scheduled daily dosing of benzodiazepines (not PRN) during 8-week treatment
Severe or instable medical condition, which clearly impacts on depression or on the ability to participate in the trial
Brain disease with severe functional impairment that impacts the ability to participate in the trial (e.g. aphasia, Parkinson's disease)
Clareo Health | Cognitive Behavioural Therapy for the Treatment of Late Life Depression
